Search by Drug Name, NDC or Jcode

    Internal Navigation

    HCPCS Details

    HCPC Q0245
    Short Description Bamlanivimab and etesevima
    Long Description Injection, bamlanivimab and etesevimab, 2100 mg
    Pricing indicator 54
    Coverage code C
    ASC payment group code
    BETOS2 code O1G
    Action code N
    Type of service V
    Effective date 2021-02-09
    Date Added 2021-02-09

    Drug Details

    • Bamlanivimab and etesevimab injection is used in certain non-hospitalized adults, children, and infants including newborns, and who have certain medical conditions that make them at higher risk for developing severe COVID-19 symptoms, including hospitalization or death:

      • to treat mild to moderate symptoms of COVID-19.

      • to prevent COVID-19 in those who are not fully vaccinated against COVID-19 or who are vaccinated, but have a weakened immune system, or are taking a medication that affects the immune system and who have had close contact or are at high risk of close contact to someone who is infected with the SARS-CoV-2 virus (for example, nursing homes, prisons).

    • Bamlanivimab and etesevimab is also used to treat mild to moderate symptoms of COVID-19 in hospitalized children and infants less than 2 years of age, including newborns.

    • Bamlanivimab and etesevimab are in a class called monoclonal antibodies. These medications work by blocking the action of a certain natural substance in the body to stop the spread of the virus.